401 filings
Page 11 of 21
POS AM
qvjdvk5gmb piw
26 Jul 05
Prospectus update (post-effective amendment)
12:00am
8-K
r4cmvmfa
26 Jul 05
Regulation FD Disclosure
12:00am
8-K
29sus cdrha3oql2
26 Jul 05
Results of Operations and Financial Condition
12:00am
8-K
auvcwfn
15 Jul 05
Entry into a Material Definitive Agreement
12:00am
8-K
z4ih6t4
21 Jun 05
Imclone Systems Names David Sidransky, M.D., Vice Chairman
12:00am
8-K
1zq au0mxs
20 Jun 05
Imclone Systems to File Sbla for Use of Erbitux In Head and Neck Cancer In Third Quarter 2005
12:00am
8-K
zqu9ty
8 Jun 05
Imclone Systems Withdraws 2005 Stock Incentive Plan from Consideration at Annual Shareholder Meeting
12:00am
8-K
1q8ry050wrdit3b
8 Jun 05
Other Events
12:00am
8-K
r0xu7swqlvwv2w4py
8 Jun 05
Imclone Systems Receives Hart-scott-rodino Notice from Carl Icahn
12:00am
8-K
jebfvd x8n
16 May 05
ERBITUX® (Cetuximab) SCIENTIFIC DATA IN SEVERAL TUMOR TYPES PRESENTED AT ASCO ANNUAL MEETING
12:00am
8-K
22p eubcg
11 May 05
Cost Associated with Exit or Disposal Activities
12:00am
ARS
f7mrxjq67
6 May 05
Annual report to shareholders
12:00am
8-K
yb36v2d 5h
28 Apr 05
Imclone Systems Reports First-quarter Financial Results
12:00am
POS AM
zs2niaxsbp07x
28 Apr 05
Prospectus update (post-effective amendment)
12:00am
8-K
chlattxk50prjz51g6
12 Apr 05
Other Events
12:00am
8-K
080fg3 lljg7e8
8 Apr 05
Entry into a Material Definitive Agreement
12:00am
8-K
faxkgzs58qm
23 Mar 05
Entry into a Material Definitive Agreement
12:00am